Search

Your search keyword '"Khan, Muhammad Shahzeb"' showing total 164 results

Search Constraints

Start Over You searched for: Author "Khan, Muhammad Shahzeb" Remove constraint Author: "Khan, Muhammad Shahzeb" Database Supplemental Index Remove constraint Database: Supplemental Index
164 results on '"Khan, Muhammad Shahzeb"'

Search Results

1. Prognostic value of quality of life and functional status in patients with heart failure: a systematic review and meta-analysis.

2. Trajectory of C-Reactive Protein and Incident Heart Failure in Black Adults: The Jackson Heart Study.

4. Global epidemiology of heart failure

5. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure

6. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis

7. Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries

10. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure

11. The spectrum of post-myocardial infarction care: From acute ischemia to heart failure.

12. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure.

13. Efficient electrocatalytic oxygen evolution by nano NiO-In2O3 electrode materials.

15. Place of death in Parkinson’s disease: trends in the USA

16. Deaths from heart failure and cancer: location trends

17. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure

18. Hospital at Home as a Treatment Strategy for Worsening Heart Failure.

19. Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.

20. Comparison of 30-day Readmission Rates and Inpatient Cardiac Procedures for Weekday Versus Weekend Hospital Admissions for Heart Failure.

23. Minimal Clinically Important Difference for Six-minute Walk Test in Patients with HFrEF and Iron Deficiency.

24. Frailty and heart failure: State‐of‐the‐art review

26. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease

27. Predicting and preventing heart failure in type 2 diabetes

28. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials.

31. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk

32. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA

33. Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review.

34. Medication-Attributable Adverse Events in Heart Failure Trials

35. Recent advancements in molecularly imprinted polymers for the removal of heavy metal ions and dyes

36. Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States

38. Subjective Financial Hardship due to Medical Bills Among Patients With Heart Failure in the United States: The 2014-2018 Medical Expenditure Panel Survey.

39. Thresholds for interpreting the fragility index derived from sample of randomised controlled trials in cardiology: a meta-epidemiologic study

40. The need for increased pragmatism in cardiovascular clinical trials

41. Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019

42. Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials.

43. Chitosan-based modalities with multifunctional attributes for adsorptive mitigation of hazardous metal contaminants from wastewater

46. Demographic and Regional Trends of Heart Failure–Related Mortality in Young Adults in the US, 1999-2019

47. Contemporary Nationwide Heart Transplantation and Left Ventricular Assist Device Outcomes in Patients with Histories of Bariatric Surgery.

48. Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018.

Catalog

Books, media, physical & digital resources